Article Information
- Received May 31, 2018
- Revision received December 18, 2021
- Accepted December 20, 2021
- Published online February 3, 2022.
Author Information
- Louise Thiry1,*,
- Chloé Lemaire1,*,
- Ali Rastqar1,*,
- Maxime Lemieux1,*,
- Jimmy Peng2,3,*,
- Julien Ferent2,3,
- Marie Roussel1,
- Eric Beaumont4,
- James P. Fawcett5,6,
- Robert M. Brownstone7,
- Frédéric Charron2,3,8,† and
- Frédéric Bretzner1,9,†
- 1Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Centre Hospitalier de l’Université Laval (CHUL)–Neurosciences P09800, Quebec City, Quebec G1V 4G2, Canada
- 2Institut de Recherches Cliniques de Montréal (IRCM), Montréal, Quebec H2W 1R7, Canada
- 3Department of Biology, McGill University, Montréal, Quebec H3G 0B1, Canada
- 4Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37604
- 5Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada
- 6Department of Surgery, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada
- 7University College London (UCL) Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom
- 8Department of Medicine, University of Montreal, Montréal, Quebec H3C 3J7, Canada
- 9Department of Psychiatry and Neurosciences, Université Laval, Quebec City, Quebec G1V 4G2, Canada
- Correspondence should be addressed to Frédéric Charron at frederic.charron{at}ircm.qc.ca or Frédéric Bretzner at frederic.bretzner.1{at}ulaval.ca.
Author contributions
Author contributions: R.M.B., J.P.F., F.C., and F.B. designed research; L.T., C.L., A.R., M.L., J.P., M.R., J.F., E.B., and F.B. performed research; L.T., C.L., A.R., M.L., J.P., M.R., J.F., E.B., F.C., and F.B. analyzed data; L.T., C.L., M.L., J.P., F.C., and F.B. wrote the paper.
↵* L.T., C.L., A.R., M.L. and J.P. contributed equally to this work.
↵† F.C. and F.B. are co-senior authors.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Canadian Institutes of Health Research (CIHR) Grant 334023, the Fonds de Recherche du Québec-Santé (FRQS) Grant 27003, and the Canada Foundation for Innovation (CFI) Grant 33768 (to F.C.); CIHR Grants MOP 341174 (to J.P.F.) and 79413 (to R.M.B.); and the Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 2018-06218 (to F.B.). J.P. was supported by a CIHR Vanier Canada Graduate scholarship. J.F. was supported by FRQS and CIHR fellowships. F.C. holds the Canada Research Chair in Developmental Neurobiology. F.B. is a FRQS Chercheur-Boursier (284011).
Funding
Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)
334023Fonds de Recherche du Québec - Santé (FRQS)
27003; 284001Canadian Foundation for Innovation
33768Gouvernement du Canada | CIHR | Institute of Neurosciences, Mental Health and Addiction (INMHA)
341174; 79413Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
2018-06218
Other Version
- You are viewing the most recent version of this article.
- previous version (February 03, 2022).
Article usage
In this issue
